Skip to search formSkip to main contentSkip to account menu

MultiStem

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Introduction: MultiStem is an adult, adherent, stem cell product, having shown safety and efficacy in other clinical… 
2016
2016
MultiStem cells are clinical‐grade multipotent adult bone marrow‐derived progenitor cells (MAPCs), with extensive replication… 
2016
2016
Stem cell therapy or “cell therapy” has been demonstrated to be a potent treatment intervention in animal models of acute… 
2016
2016
Introduction: B01-02 was a double-blind, placebo-controlled study of ischemic stroke patients (NIHSS 8-20, inclusive) treated… 
Review
2015
Review
2015
The translation of stem cell therapeutics, from experimental testing in preclinical animal models to clinical evaluation in human… 
2012
2012
Background: There is increasing evidence to suggest that some types of stem cells enhance recovery after stroke by exerting… 
2011
2011
Athersys (Nasdaq: ATHX) is a biopharmaceutical company engaged in the discovery and development of novel therapies designed to… 
2011
2011
Abstract 1987 Background. MultiStem®, a multipotent adult progenitor cells (MAPC) collection, is an immune-modulatory, bone…